Citations

Clear

6274 citation(s) found for "To, Andrew".

A Six-Week Follow-Up Study on the Sustained Effects of Prolonged Water-Only Fasting and Refeeding on Markers of Cardiometabolic Risk
Gabriel, Sahmla , Ncube, Mackson, Zeiler, Evelyn , Thompson, Natasha , Karlsen, Micaela, Goldman, David , Glavas, Zrinka, Beauchesne, Andrew R. , Scharf, Eugene , Goldhamer, Alan , Myers, Toshia R. , Karlsen, Micaela , Goldhamer, Alan C , Scharf, Eugene L , Karlsen, Micaela C

Mayo Clinic

Nutrients | October 17, 2022 | Volume: 14 | Issue: 20 | Pages: 4313

10.3390/nu14204313 | PMID 36296997 Get It

(1) Background: Chronic inflammation and insulin resistance are associated with cardiometabolic diseases, such as cardiovascular disease, type 2 diabetes mellitus, and non-alcoholic fatty liver disease. Therapeutic water-only fasting and whole-plant-food refeeding was previously shown to improve markers of cardiometabolic risk and may be an effective preventative treatment but sustained outcomes are unknown. We conducted a single-arm, open-label, observational study with a six-week post-treatment follow-up visit to assess the effects of water-only fasting and refeeding on markers of cardiometabolic risk. (2) Methods: Patients who had voluntarily elected and were approved to complete a water-only fast were recruited from a single-center residential medical facility. The primary endpoint was to describe changes to Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) scores between the end-of-refeed visit and the six-week follow-up visit. Additionally, we report on changes in anthropometric measures, blood lipids, high-sensitivity C-reactive protein (hsCRP), and fatty liver index (FLI). Observations were made at baseline, end-of-fast (EOF), end-of-refeed (EOR), and six-week follow-up (FU). (3) Results: The study enrolled 40 overweight/obese non-diabetic participants, of which 33 completed the full study protocol. Median fasting, refeeding, and follow-up lengths were 14, 6, and 45 days, respectively. At the FU visit, body weight (BW), body mass index (BMI), abdominal circumference (AC), systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), low-density lipoprotein (LDL), hsCRP, and FLI were significantly decreased from baseline. Triglycerides (TG) and HOMA-IR scores, which had increased at EOR, returned to baseline values at the FU visit. (4) Conclusion: Water-only fasting and whole-plant-food refeeding demonstrate potential for long-term improvements in markers of cardiovascular risk including BW, BMI, AC, SBP, DBP, blood lipids, FLI, and hsCRP.
NCCN Guidelines® Insights: Survivorship, Version 1.2022
Sanft, Tara , Peterson, Lindsay L. , Rodriguez, Maria Alma , Ansbaugh, Shannon, Demark‐Wahnefried, Wendy , Dickinson, Kristin , Fairman, Nathan, Goldman, Mindy, Henry, N. Lynn , Hill‐Kayser, Christine E. , Khakpour, Nazanin , Koura, Divya, McDonough, Allison L. , Melisko, Michelle , Mooney, Kathi , Moryl, Natalie , Neuman, Heather B. , Patel, Chirayu G. , Porpiglia, Andrea S., Ruddy, Kathryn J. , Schapira, Lidia , Shockney, Lillie D. , Syrjala, Karen L. , Yang, Eric H. , Zee, Phyllis C. , McMillian, Nicole R., Freedman-Cass, Deborah A., Broderick, Gregory, Henry, N Lynn , Yang, Eric , Demark-Wahnefried, Wendy , Day, Andrew T. , Armenian, Saro H. , Baker, Kevin Scott , Ballinger, Tarah Jean , Broderick, Gregory A. , Friedman, Debra L. , Hudson, Melissa M. , Moore, Halle C. F. , O’Connor, Tracey L. , Overholser, Linda , Paskett, Electra D. , Pirl, William F. , Smith, Sophia K. , Tevaarwerk, Amyé

Mayo Clinic

Journal of the National Comprehensive Cancer Network | October 14, 2022 | Volume: 20 | Issue: 10 | Pages: 1080-1090

10.6004/jnccn.2022.0052 | PMID 36240847 Get It

The NCCN Guidelines for Survivorship are intended to help healthcare professionals who work with survivors to ensure that the survivors’ complex and varied needs are addressed. The NCCN Guidelines provide screening, evaluation, and treatment recommendations for the consequences of adult-onset cancer and its treatment; recommendations to help promote physical activity, weight management, and immunizations in survivors; and a framework for care coordination. This article summarizes updates to the NCCN Guidelines pertaining to preventive health for cancer survivors, including recommendations about alcohol consumption and vaccinations.
Real-Time Dual Video Conferencing of Simulated Tracheostoma Maturation During Residency Interviews
Goates, Andrew J. , Macielak, Robert J. , McMillan, Ryan A. , Bisco, Susan E. , Bayan, Semirra L. , Stokken, Janalee K. , Carlson, Matthew L , Bayan, Semirra

Mayo Clinic

Journal of Graduate Medical Education | October 14, 2022 | Volume: 14 | Issue: 5 | Pages: 613-616

10.4300/jgme-d-22-00142.1 | PMID 36274763 Get It

ABSTRACT Background There are few reports of dexterity tests being done in a distance telecommunication setting for residency applicant evaluation. Objective To report the feasibility and suitability of a virtual suturing skills assessment during residency interviews when added to the standard assessment process. Methods A suturing simulation was developed and implemented during otolaryngology–head and neck surgery (OHNS) residency interviews for the 2020-2021 cycle at one program. On the day of the interview, the activity was completed in real time using 2-camera video conferencing with the 2 resident assessors providing a numerical assessment based on an adapted scoring rubric from prior suturing activities at the institution. The exercise involved suturing a 3/4-inch Penrose drain circumferentially with half-vertical mattress stitches to simulate the maturation of a tracheostoma. The residency selection committee then completed a 7-item Likert-type survey, developed by the authors, to evaluate the simulation exercise. Results Fifty-one applicants representing all interviewees in the cycle successfully completed this assessment without technologic disruptions. The total cost associated with obtaining and providing the necessary supplies to applicants was $34.78 per interviewee. Time required to complete the suturing task was estimated to range from 10 to 20 minutes. The residency selection committee viewed this exercise as a success (14 of 16, 87.5%) and viewed the results as a valuable adjunct in the overall assessment of candidates (15 of 16, 93.8%). Conclusions A simple motor exercise completed over real-time telecommunication was feasible and perceived as helpful to the residency selection committee when assessing OHNS residency candidates.
Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Benson, Al B. , Al-Hawary, Mahmoud M. , Azad, Nilofer, Chen, Yi‐Jen , Cooper, Harry S. , Deming, Dustin A. , Garrido‐Laguna, Ignacio , Grem, Jean L. , Hecht, J. Randolph, Hoffe, Sarah E. , Hunt, Steven R., Johung, Kimberly L. , Kirilcuk, Natalie, Krishnamurthi, Smitha , Maratt, Jennifer K. , Messersmith, Wells A. , Meyerhardt, Jeffrey A. , Mulcahy, Mary F. , Nurkin, Steven, Overman, Michael J. , Parikh, Aparna, Patel, Hitendra , Shibata, David , Skibber, John M., Sofocleous, Constantinos T. , Stotsky‐Himelfarb, Eden, Tavakkoli, Anna , Willett, Christopher G. , Gregory, Kristina M., Gurski, Lisa A., Meyerhardt, Jeffrey A , Venook, Alan P. , Ciombor, Kristen K. , Cohen, Stacey A. , Gunn, Andrew, Hubbard, Joleen M. , Jeck, William R. , Miller, Eric D. , Patel, Hitendra, Pedersen, Katrina S. , Saltz, Leonard B. , Schneider, Charles John

Mayo Clinic

Journal of the National Comprehensive Cancer Network | October 14, 2022 | Volume: 20 | Issue: 10 | Pages: 1139-1167

10.6004/jnccn.2022.0051 | PMID 36240850 Get It

This selection from the NCCN Guidelines for Rectal Cancer focuses on management of malignant polyps and resectable nonmetastatic rectal cancer because important updates have been made to these guidelines. These recent updates include redrawing the algorithms for stage II and III disease to reflect new data supporting the increasingly prominent role of total neoadjuvant therapy, expanded recommendations for short-course radiation therapy techniques, and new recommendations for a “watch-and-wait” nonoperative management technique for patients with cancer that shows a complete response to neoadjuvant therapy. The complete version of the NCCN Guidelines for Rectal Cancer, available online at NCCN.org , covers additional topics including risk assessment, pathology and staging, management of metastatic disease, posttreatment surveillance, treatment of recurrent disease, and survivorship.
Effect of endoscopic sleeve gastroplasty on gastric emptying, motility and hormones: a comparative prospective study
Rizk, Monika, Gomez-Villa, Jacky, Edwards, Phillip K , Jaruvongvanich, Veeravich , Acosta, Andrés , Lake, David S. , Fidler, Jeff L. , Bharucha, Adil E. , Camilleri, Michael , Vargas, Eric J , Acosta, Andres , Lake, David, Fidler, Jeff, Bharucha, A E , Camilleri, M , Abu Dayyeh, Barham K , Vargas, Eric J. , Storm, Andrew C. , Fidler, Jeff L. , Dayyeh, Barham K. Abu

Mayo Clinic

Gut | October 14, 2022 | Volume: 72 | Issue: 6 | Pages: 1073-1080

10.1136/gutjnl-2022-327816 | PMID 36241388 Get It

Objective Endoscopic sleeve gastroplasty (ESG) has gained global adoption but our understanding of its mechanism(s) of action and durability of efficacy is limited. We sought to determine changes in gastric emptying (GE), gastric motility (GM), hormones and eating behaviours after ESG. Design A priori-designed single-centre substudy of a large US randomised clinical trial, adults with obesity were randomised to ESG or lifestyle interventions (LS) alone. We measured GE, hormones and weight loss and assessed eating behaviours. In a subset of ESG patients, we assessed GM. The primary outcome was the change in T1/2 (min) at 3 months, and secondary outcomes were changes in weight, GE, GM, hormones and eating behaviours. We used t-test analyses and regression to determine the association between GE and weight loss. Results 36 (ESG=18; LS=18) participated in this substudy. Baseline characteristics were similar between the two groups. At 3 months, T1/2 was delayed in the ESG group (n=17) compared with the LS group (n=17) (152.3±47.3 vs 89.1±27.9; p<0.001). At 12 months, T1/2 remained delayed in the ESG group (n=16) vs control group (n=14) (137±37.4 vs 90.1±23.4; p<0.001). Greater delays in GE at 3 months were associated with greater weight loss. GM was preserved and fasting ghrelin, glucagon-like peptide 1 and polypeptide YY significantly increased 18 months after ESG. Conclusion ESG promotes weight loss through several key mechanistic pathways involving GE and hormones while preserving GM. These findings further support clinical adoption of this technique for the management of obesity. Trial registration number NCT03406975.
Leveraging machine learning to ascertain the implications of preoperative body mass index on surgical outcomes for 282 patients with preoperative obesity and lumbar spondylolisthesis in the Quality Outcomes Database
Agarwal, Nitin , Chan, Andrew K. , Shabani, Saman , Bisson, Erica F. , Bydon, Mohamad , Glassman, Steven D. , Foley, Kevin T. , Shaffrey, Christopher I. , Potts, Eric A. , Shaffrey, Mark E., Coric, Domagoj , Knightly, John J. , Park, Paul , Wang, Michael Y. , Fu, Kai-Ming, Slotkin, Jonathan R., Asher, Anthony L. , Virk, Michael S. , Haid, Regis W., Chou, Dean , Mummaneni, Praveen V. , Aabedi, Alexander A. , Letchuman, Vijay

Mayo Clinic

Journal of Neurosurgery: Spine | October 14, 2022 | Volume: 38 | Issue: 2 | Pages: 182-191

10.3171/2022.8.spine22365 | PMID 36208428 Get It

OBJECTIVE Prior studies have revealed that a body mass index (BMI) ≥ 30 is associated with worse outcomes following surgical intervention in grade 1 lumbar spondylolisthesis. Using a machine learning approach, this study aimed to leverage the prospective Quality Outcomes Database (QOD) to identify a BMI threshold for patients undergoing surgical intervention for grade 1 lumbar spondylolisthesis and thus reliably identify optimal surgical candidates among obese patients. METHODS Patients with grade 1 lumbar spondylolisthesis and preoperative BMI ≥ 30 from the prospectively collected QOD lumbar spondylolisthesis module were included in this study. A 12-month composite outcome was generated by performing principal components analysis and k-means clustering on four validated measures of surgical outcomes in patients with spondylolisthesis. Random forests were generated to determine the most important preoperative patient characteristics in predicting the composite outcome. Recursive partitioning was used to extract a BMI threshold associated with optimal outcomes. RESULTS The average BMI was 35.7, with 282 (46.4%) of the 608 patients from the QOD data set having a BMI ≥ 30. Principal components analysis revealed that the first principal component accounted for 99.2% of the variance in the four outcome measures. Two clusters were identified corresponding to patients with suboptimal outcomes (severe back pain, increased disability, impaired quality of life, and low satisfaction) and to those with optimal outcomes. Recursive partitioning established a BMI threshold of 37.5 after pruning via cross-validation. CONCLUSIONS In this multicenter study, the authors found that a BMI ≤ 37.5 was associated with improved patient outcomes following surgical intervention. These findings may help augment predictive analytics to deliver precision medicine and improve prehabilitation strategies.
Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing‐off of erenumab within monthly treatment cycle
Dodick, David W. , Blumenfeld, Andrew , Singh, Rashmi B. Halker , Hsu, Cheng‐Pang, Peng, Cheng , Snellman, Josefin , Chehrenama, Mahan, Blumenfeld, Andrew M , Halker Singh, Rashmi B , Ailani, Jessica , Dodick, David W , Williams, Rachel , Zhang, Feng , Chen, Po‐Wei , Ailani, Jessica

Mayo Clinic

Headache: The Journal of Head and Face Pain | October 13, 2022 | Volume: 63 | Issue: 2 | Pages: 233-242

10.1111/head.14403 | PMID 36226464 Get It

Abstract Background Treatment wearing‐off has been reported for calcitonin gene‐related peptide‐pathway monoclonal antibodies, including erenumab, specifically in the last week of the monthly dosing cycle. Objective We sought to determine the consistency of erenumab effect throughout the monthly treatment cycle. Methods In this post hoc analysis of four pivotal double‐blind, randomized controlled studies of erenumab in episodic and chronic migraine, we assessed wearing‐off based on change in weekly migraine days at week 4 versus average over weeks 1–3 in each monthly dosing cycle. Analyses were conducted at each monthly dosing cycle in all patients, in responders (≥50% reduction in weekly migraine days), and in consistent responders (response in ≥2monthly cycles). Results There was no evidence of wearing‐off in the full study populations of two global studies (N = 946 and N = 656) and two Japan studies (N = 475 and N = 261). In the full study population, mean change in weekly migraine days at week 4 compared with the average over week 1–3 ranged from 0.15 days improvement to 0.19 days worsening in the placebo group and 0.08 days improvement to 0.20 days worsening in the erenumab groups. A subgroup of responders experienced wearing‐off, but the extent of wearing‐off did not differ between erenumab and placebo groups. The mean change in weekly migraine days at week 4 compared with the average over weeks 1–3 ranged from 0.34 to 0.61 days worsening in the placebo group and 0.27 to 0.78 days worsening in the erenumab groups. Few patients had persistent wearing‐off in ≥2 consecutive monthly treatment cycles. For erenumab‐treated responders, serum erenumab concentrations were similar among patients experiencing wearing‐off and those maintaining response. Conclusion No systematic wearing‐off with erenumab was identified. Further research is needed to determine if wearing‐off reported for some patients in clinical practice reflects a true treatment response pattern or normal fluctuations in migraine frequency.
Pim-1 kinase is a positive feedback regulator of the senescent lung fibroblast inflammatory secretome
Gao, Ashley Y. , Espinosa, Ana Maria Diaz, Gianì, Fiorenza , Pham, Tho X., Aravamudhan, Aja, Bartman, Colleen M. , Ligresti, Giovanni , Caporarello, Nunzia , Schafer, Marissa , Haak, Andrew J. , Espinosa, Ana M. Diaz , Diaz Espinosa, Ana M , Carver, Chase M., Bartman, Colleen M , Caporarello, Nunzia , Schafer, Marissa J , Haak, Andrew J , Carver, Chase Matthew

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | October 12, 2022 | Volume: 323 | Issue: 6 | Pages: L685-L697

10.1152/ajplung.00023.2022 | PMID 36223640 Get It

Cellular senescence is emerging as a driver of idiopathic pulmonary fibrosis (IPF), a progressive and fatal disease with limited effective therapies. The senescence-associated secretory phenotype (SASP), involving the release of inflammatory cytokines and profibrotic growth factors by senescent cells, is thought to be a product of multiple cell types in IPF, including lung fibroblasts. NF-κB is a master regulator of the SASP, and its activity depends on the phosphorylation of p65/RelA. The purpose of this study was to assess the role of Pim-1 kinase as a driver of NF-κB-induced production of inflammatory cytokines from low-passage IPF fibroblast cultures displaying markers of senescence. Our results demonstrate that Pim-1 kinase phosphorylates p65/RelA, activating NF-κB activity and enhancing IL-6 production, which in turn amplifies the expression of PIM1, generating a positive feedback loop. In addition, targeting Pim-1 kinase with a small molecule inhibitor dramatically inhibited the expression of a broad array of cytokines and chemokines in IPF-derived fibroblasts. Furthermore, we provide evidence that Pim-1 overexpression in low-passage human lung fibroblasts is sufficient to drive premature senescence, in vitro. These findings highlight the therapeutic potential of targeting Pim-1 kinase to reprogram the secretome of senescent fibroblasts and halt IPF progression.
On Surviving the Whitewater Regatta: Navigating the Hidden Current of Medical Training
Yang, Andrew X.

Mayo Clinic

Academic Medicine | October 12, 2022 | Volume: 98 | Issue: 7 | Pages: 757-758

10.1097/acm.0000000000004980 | PMID 36222524 Get It

Imaging of pediatric pancreas tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper
Eklund, Meryle J., Acord, Michael R. , Behr, Gerald , El‐Ali, Alexander M. , Morin, Cara E. , Saigal, Gaurav , Shet, Narendra , Thacker, Paul G. , Behr, Gerald G , Thacker, Paul G , Trout, Andrew T , States, Lisa J. , Alazraki, Adina , Trout, Andrew T.

Mayo Clinic

Pediatric Blood & Cancer | October 10, 2022 | Volume: 70 | Issue: S4 | Pages: No page available

10.1002/pbc.29975 | PMID 36215203 Get It

AbstractPrimary pancreatic tumors in children are rare with an overall age‐adjusted incidence of 0.018 new cases per 100,000 pediatric patients. The most prevalent histologic type is the solid pseudopapillary neoplasm, followed by pancreatoblastoma. This paper describes relevant imaging modalities and presents consensus‐based recommendations for imaging at diagnosis and follow‐up.